Largest medical device market in the Central & Eastern Europe (CEE) region.  Per capita spending is low for the CEE region.  Market will record high single-digit growth in local currency terms. Other medical devices and diagnostic imaging have the largest market shares. The government has increased the number of medical devices subject to import restrictions, which could negatively impact the sales of foreign manufacturers. Import shares may fall by 2020, in accordance with the Ministry of Industry and Trade's import substitution plan, which aims to reduce the import shares of 111 groups of medical devices. The greatest opportunities exist around the major cities of Moscow and St Petersburg, where most companies are based and per capita incomes are well above the national average.

Russian petrochemicals output grew at a faster rate than industrial growth in 2017. Russian chemicals output grew 4.3% in 2017, largely due to growth in fertilizer, according to Rosstat data. Ethylene output rose 2.5% to 2.86mn tonnes, benzene grew 4.2% to 1.36mn tonnes, caustic soda was up 6.1% to 1.24mn tonnes and mineral fertilizer production grew 8.2% to 22.52mn tonnes. In contrast, industrial growth was just 1.8%. Higher oil prices are spurring the domestic economy following several years of stagnation, but this trend has also hiked naphtha prices and raised the cost of production at a time when markets have been limited by US and EU sanctions.

Silicon carbide (SiC) power semiconductor is a power device, which is used to control the distribution of power in an electronics system. The wider band gap, high switching frequency, and high electric field strength of SiC power devices allow them to be operated at higher temperatures and volumes as compared to their silicon counterparts. the silicon carbide power devices market has witnessed significant growth, owing to increasing number of industrial sectors that require SiC power devices such as manufacturing, automotive, and energy & power sectors.

The silicon wafer reclaim market is segmented on basis of product as 150 mm, 200 mm, 300mm, and others, which include 450 mm silicon wafer. The 300 mm was the largest product segment, accounting over 70% of global silicon wafers reclaim market revenue in 2015. Increasing demand for silicon wafer for manufacturing solar panels, solar cells, and integrated circuits is expected to drive demand for silicon wafer reclaim over the next eight years.

Singapore's Energy Market Authority manages the Singaporean oil and gas sector and regulates the domestic electricity and natural gas industries. The city-state's sophisticated downstream sector, strategic location, extensive infrastructure and low-risk operating environment allow it to flourish as a regional refining and petrochemicals hub. State-owned Pavilion Energy is responsible for the marketing, distribution and storage of natural gas in Singapore, including small-scale LNG and LNG bunkering.

Sixth smallest market in the CEE region. Per capita spending is well above regional average. Market will record a mid single-digit US dollar CAGR. Other medical devices and consumables have the largest market shares. Most requirements are imported, largely from other EU countries. Local production of basic items is strong but geared to exports. Comprehensive public health insurance system. Relatively robust private health insurance sector. Slovenia has long had a good reputation in specialist areas such as dentistry, attracting patients from neighbouring countries.

One of the largest markets in the Middle East & Africa (MEA) region, similar in size to Iran. Market size is supported by a large population and Africa's most industrialised economy. Owing to the size of the population, per capita spending is low. Spending on medical devices as a proportion of wealth is below average for the MEA region. Other medical devices accounts for nearly 40% of the total market. Underdeveloped market offers considerable potential for growth but currently constrained by funding issues, poor infrastructure and staff shortages. National Health Insurance programme in the early stages of implementation, but question marks remain on funding and delivery of key targets. Limited medical device production, therefore market largely dependent on imports.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. OTC medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. Over-the-counter (OTC) medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.

South Korea's food industry is fairly well developed, producing traditional and modern food products. The industry is sophisticated and relies heavily on imports of raw materials, intermediate products, ingredients and additives. Other than rice and certain dairy products, in which it is self-sufficient, South Korea imports almost all types of agricultural products for processing. South Korean agriculture has long been plagued by the country's climatic and topographic unsuitability and accordant scarcity of agricultural land. In the past, government policy has also been viewed as impeding output growth, with tightly controlled limits in place on the ownership of agricultural land and tight restrictions on trade. However, faced with a growing food import bill, the government appears to be changing its stance.